Mesoblast Ltd
NASDAQ:MESO

Watchlist Manager
Mesoblast Ltd Logo
Mesoblast Ltd
NASDAQ:MESO
Watchlist
Price: 19.42 USD -0.31% Market Closed
Market Cap: 2.2B USD

Wall Street
Price Targets

MESO Price Targets Summary
Mesoblast Ltd

Wall Street analysts forecast MESO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MESO is 20.25 USD with a low forecast of 19.81 USD and a high forecast of 21.21 USD.

Lowest
Price Target
19.81 USD
2% Upside
Average
Price Target
20.25 USD
4% Upside
Highest
Price Target
21.21 USD
9% Upside
Mesoblast Ltd Competitors:
Price Targets
GOSS
Gossamer Bio Inc
155% Upside
AZT
Arcticzymes Technologies ASA
54% Upside
688180
Shanghai Junshi Biosciences Co Ltd
24% Downside
RARE
Ultragenyx Pharmaceutical Inc
141% Upside
VCYT
Veracyte Inc
14% Upside
FOLD
Amicus Therapeutics Inc
14% Upside
EDT
Spectral Medical Inc
145% Upside
PRQR
ProQR Therapeutics NV
356% Upside

Revenue
Forecast

Revenue Estimate
Mesoblast Ltd

For the last 13 years the compound annual growth rate for Mesoblast Ltd's revenue is -6%. The projected CAGR for the next 3 years is 178%.

-6%
Past Growth
178%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Mesoblast Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Mesoblast Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MESO's stock price target?
Price Target
20.25 USD

According to Wall Street analysts, the average 1-year price target for MESO is 20.25 USD with a low forecast of 19.81 USD and a high forecast of 21.21 USD.

What is Mesoblast Ltd's Revenue forecast?
Projected CAGR
178%

For the last 13 years the compound annual growth rate for Mesoblast Ltd's revenue is -6%. The projected CAGR for the next 3 years is 178%.

Back to Top